Header Ads

Treating a virus threat like terrorism

Coronavirus Daily
Bloomberg

Here's the latest news from the global pandemic. 

Treating a virus threat like terrorism

After the 9/11 attacks, the U.S. government "tracked every single phone call coming into the U.S., a pretty revolutionary piece of surveillance," according to Peter Daszak of EcoHealth Alliance, a nonprofit working to prevent viral outbreaks around the world.

"Why aren't we doing that with pandemics?" he said Thursday at the Bloomberg New Economy Forum.

He wasn't really suggesting monitoring telephone calls, but he was making a point. Why aren't viruses viewed as national security threats and tracked with the same intensity that governments use to monitor terrorist activity?

It's a good question, and one of the answers might be a lack of early-warning systems. Daszak and two other top virus hunters who appeared on a panel with him said that nations need to invest in systems that would detect emerging viruses before they infect people and then spread.

"We haven't had the kind of early-warning system and investment in this kind of early-warning system that we've needed from the very beginning," said Anne Rimoin, a professor or epidemiology at the UCLA Fielding School of Public Health. "We really need to be able to invest in protecting ourselves from viruses."

Viral outbreaks are "happening more frequently, they're spreading quicker, they're killing more people and they're crushing our economies," said Daszak. He estimated that there are 1.7 million unknown viruses in the world. It would cost over a $1 billion to identify 70% of them, but it would be money well spent, Daszak said.

Maybe the money should come from national security budgets.—Robert Langreth and Mark Schoifet

Latest podcast

Can We Make Enough Covid Drugs?

Riley Griffin speaks to Eli Lilly CEO David Ricks about the challenges facing the company and its new Covid-19 treatment amid the worsening pandemic. Get the episode here

 

What you should read

WHO Advises Against Remdesivir Use for Covid
U.S. regulators granted the drug a speedy approval less than a month ago. 
World's Firms Chose Men to Lead in Pandemic
Women have made up just 3% of CEO picks around the world since March.
Questionable Testing Belies India's Drop in Cases
Daily cases have halved since peak of more than 97,000 in mid-September.
Sweden Rejects Face Masks Amid Virus Surge
Skepticism comes amid rapid virus spread, more people in intensive care. 
Covid Tracking Project Data Heroes Fill U.S. Void
Volunteer effort has become a vital source of information on the pandemic.

Know someone else who would like this newsletter? Have them sign up here.

Have any questions, concerns, or news tips on Covid-19 news? Get in touch or help us cover the story.

Like this newsletter? Subscribe for unlimited access to trusted, data-based journalism in 120 countries around the world and gain expert analysis from exclusive daily newsletters, The Bloomberg Open and The Bloomberg Close.

No comments